Healthcare & Pharmaceuticals
MERU CASE STUDY
Identified $1.6M of EBITDA for a healthcare staffing company
- ~$100M healthcare staffing company that had acquired 4 companies in 12 months
- The Company’s investors wanted an outside perspective on organization structure, SG&A cost and margin improvement opportunities
- The goal was to align the organization structure to allow for growth of existing businesses and align the company toward an exit in 18-24 months
Identified organizational structure changes worth $0.8-1.6M of incremental EBITDA while better aligning client for desired growth, improved strategic planning and execution, and achievement of financial metrics.
Identified gross margin opportunities worth $0.8-2.3M in EBITDA including implementing payment discount for managed care business, eliminating low gross margin assignments, changing comp recruiter cost structure, and changing travel reimbursement practices.
New executive compensation and non-executive compensation structures were identified to align incentives with performance.